- Home
- ILMN vs WAT Comparison
ILMN vs WAT Comparison
Compare ILMN & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- WAT
- Stock Information
- Founded
- ILMN 1998
- WAT 1958
- Country
- ILMN United States
- WAT United States
- Employees
- ILMN N/A
- WAT N/A
- Industry
- ILMN Medical Specialities
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- ILMN Health Care
- WAT Industrials
- Exchange
- ILMN Nasdaq
- WAT Nasdaq
- Market Cap
- ILMN 23.6B
- WAT 22.5B
- IPO Year
- ILMN 2000
- WAT 1995
- Fundamental
- Price
- ILMN $134.96
- WAT $376.70
- Analyst Decision
- ILMN Buy
- WAT Hold
- Analyst Count
- ILMN 17
- WAT 13
- Target Price
- ILMN $163.12
- WAT $379.00
- AVG Volume (30 Days)
- ILMN 2.1M
- WAT 486.3K
- Earning Date
- ILMN 02-06-2025
- WAT 02-04-2025
- Dividend Yield
- ILMN N/A
- WAT N/A
- EPS Growth
- ILMN N/A
- WAT N/A
- EPS
- ILMN N/A
- WAT 10.48
- Revenue
- ILMN $4,390,000,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- ILMN N/A
- WAT $0.53
- Revenue Next Year
- ILMN $4.05
- WAT $5.65
- P/E Ratio
- ILMN N/A
- WAT $35.96
- Revenue Growth
- ILMN N/A
- WAT N/A
- 52 Week Low
- ILMN $97.36
- WAT $279.24
- 52 Week High
- ILMN $156.66
- WAT $397.02
- Technical
- Relative Strength Index (RSI)
- ILMN 40.09
- WAT 52.32
- Support Level
- ILMN $130.31
- WAT $354.37
- Resistance Level
- ILMN $137.69
- WAT $379.00
- Average True Range (ATR)
- ILMN 5.13
- WAT 9.22
- MACD
- ILMN -1.03
- WAT -1.66
- Stochastic Oscillator
- ILMN 21.69
- WAT 52.34
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.